How kisspeptin signaling connects KISS1R, GnRH, and LH

Prepared by Amplified Labs

Kisspeptin sits near the top of the hormonal chain that controls reproduction. It acts on a receptor in the brain, and the signal reaches the pituitary hormones LH and FSH. This explainer traces that pathway. It also separates the body's own kisspeptins from the ten-amino-acid fragment used in some studies, and explains why the human study measured LH.

The pathway at a glance

Kisspeptin
   ↓ binds
KISS1R (also called GPR54), on GnRH neurons in the hypothalamus
   ↓ activates
GnRH release
   ↓ acts on
Pituitary gland
   ↓ releases
LH and FSH into the bloodstream

Each arrow marks one step in the signaling sequence. Kisspeptin activates its receptor. The GnRH neurons respond by releasing GnRH. GnRH then signals the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

Endogenous kisspeptins and the ten-amino-acid fragment

The KISS1 gene encodes a precursor protein that is processed into peptides of several lengths. These are collectively called kisspeptins. "Kisspeptin-10" refers to a ten-amino-acid sequence at the C-terminal end, which the longer forms share.

The distinction matters when reading studies. A finding about kisspeptin signaling in general is not automatically a finding about kisspeptin-10. A kisspeptin-10 study, such as the one by George et al. described below, tells you about that fragment under that study's conditions.

What gets measured and what gets inferred

GnRH is released into a small, local blood supply that links the hypothalamus to the pituitary. In typical human studies, that supply isn't practical to sample. LH, by contrast, circulates in the general bloodstream, so it can be measured in blood samples taken over time. LH is therefore the common measured endpoint.

LH is released in pulses. A change in how often those pulses occur is often read as a sign of changed GnRH activity upstream. That reading is reasonable, but it is an interpretation of the pathway, not a direct GnRH measurement.

When a study reports LH, it measured LH. When it discusses GnRH, check whether GnRH was actually measured or is part of the authors' explanation.

Two kinds of evidence

The evidence for this pathway comes from two different directions.

Genetic and animal evidence for the receptor's role. Seminara et al. (2003) reported human genetic cases in which mutations in GPR54 were associated with failure of normal pubertal development. Mice lacking the gene showed a comparable reproductive phenotype. Together, these findings support a role for GPR54 in puberty.

Han et al. (2005) worked in a mouse model. They showed that kisspeptin activates GnRH neurons and proposed this activation as a neuroendocrine switch at puberty onset.

These studies address whether the receptor matters and which cells respond. They are not measurements of a kisspeptin fragment's effect in people.

Controlled endocrine measurement in humans. George et al. (2011) studied kisspeptin-10 in men under controlled study conditions. They reported an LH response and an increase in LH pulse frequency.

This is direct measurement of the endpoint that circulates in blood. It is limited to that population, that fragment, and that study design.

None of these studies, alone or together, shows improved fertility. They don't support clinical interpretation or dosing decisions. They show how parts of a signaling pathway were identified and measured.

For more on how the genetics and hormone studies fit together, read Amplified Labs’ overview of kisspeptin and reproductive hormone research.

References